BR112012033625A2 - método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico - Google Patents
método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológicoInfo
- Publication number
- BR112012033625A2 BR112012033625A2 BR112012033625A BR112012033625A BR112012033625A2 BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2 BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2
- Authority
- BR
- Brazil
- Prior art keywords
- bound
- protein
- uremic toxins
- determining
- content
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 239000002441 uremic toxin Substances 0.000 title abstract 4
- 239000013060 biological fluid Substances 0.000 title abstract 3
- BXFFHSIDQOFMLE-UHFFFAOYSA-N indoxyl sulfate Chemical compound C1=CC=C2C(OS(=O)(=O)O)=CNC2=C1 BXFFHSIDQOFMLE-UHFFFAOYSA-N 0.000 abstract 2
- 230000003287 optical effect Effects 0.000 abstract 2
- 102000015736 beta 2-Microglobulin Human genes 0.000 abstract 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 abstract 1
- 230000003595 spectral effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Cell Biology (AREA)
- Optics & Photonics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EEP201000056A EE05676B1 (et) | 2010-06-28 | 2010-06-28 | Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide mramiseks bioloogilistes vedelikes |
| EEP201000085A EE05669B1 (et) | 2010-12-10 | 2010-12-10 | Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide mramiseks bioloogilistes vedelikes |
| PCT/EE2011/000008 WO2012000521A1 (en) | 2010-06-28 | 2011-06-28 | A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012033625A2 true BR112012033625A2 (pt) | 2016-10-25 |
Family
ID=44508544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012033625A BR112012033625A2 (pt) | 2010-06-28 | 2011-06-28 | método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9103789B2 (https=) |
| EP (1) | EP2585830B1 (https=) |
| JP (1) | JP5957450B2 (https=) |
| KR (1) | KR101848527B1 (https=) |
| CN (1) | CN102985822A (https=) |
| AU (1) | AU2011274009B2 (https=) |
| BR (1) | BR112012033625A2 (https=) |
| CA (1) | CA2837488C (https=) |
| NZ (1) | NZ605685A (https=) |
| WO (1) | WO2012000521A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012112790A1 (de) * | 2012-12-20 | 2014-06-26 | B. Braun Avitum Ag | Verfahren und Vorrichtung zur Bestimmung von Abfallprodukten wie Indoxyl Sulfate in der Dialyse |
| CN105264087B (zh) * | 2013-02-19 | 2019-06-18 | 尼普洛株式会社 | 羟基吲哚硫酸的测定方法 |
| CN104991026A (zh) * | 2015-06-29 | 2015-10-21 | 苏州东辰林达检测技术有限公司 | 尿液中甲基马尿酸的检测方法 |
| EP3537135A1 (en) * | 2018-03-05 | 2019-09-11 | Tallinn University of Technology | A device and method for assessment of a concentration of free pentosidine in a spent dialysate |
| JP7207702B2 (ja) * | 2018-11-06 | 2023-01-18 | 国立研究開発法人農業・食品産業技術総合研究機構 | 成分抽出方法、蛍光指紋測定装置、及びコンピュータが実行可能なプログラム |
| GB202104698D0 (en) * | 2021-03-31 | 2021-05-12 | Tallinn Univ Of Technology | Multiparametric optical method and apparatus for the determination of uremic solutes, including uremic toxins, in biological fluids |
| TWI838830B (zh) * | 2022-04-08 | 2024-04-11 | 財團法人工業技術研究院 | β2-微球蛋白濃度的分析方法及裝置 |
| CN120948421B (zh) * | 2025-10-15 | 2026-02-06 | 天津医科大学 | 一种定量-判别一体化尿毒症智能检测系统 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3261264B2 (ja) | 1994-07-13 | 2002-02-25 | 株式会社堀場製作所 | 多成分水溶液の分析方法およびその分析装置 |
| WO1998019592A1 (en) * | 1996-11-01 | 1998-05-14 | Rio Grande Medical Technologies, Inc. | Dialysis monitoring method and apparatus |
| US6261848B1 (en) | 1998-05-08 | 2001-07-17 | The Johns Hopkins University | Miniature immuno-optical rapid analyte sensor platform |
| SE525639C2 (sv) | 1998-06-04 | 2005-03-22 | Thore Falkvall | Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor |
| AUPR748501A0 (en) * | 2001-09-04 | 2001-09-27 | Life Therapeutics Limited | Renal dialysis |
| US8337444B2 (en) * | 2001-05-22 | 2012-12-25 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis |
| RU2212029C1 (ru) | 2001-12-03 | 2003-09-10 | Общество с ограниченной ответственностью "Клиника экстракорпоральной гемокоррекции" | Способ анализа жидкой биологической среды в процессе мониторинга |
| US7002670B2 (en) * | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
| WO2005003744A1 (ja) * | 2003-07-03 | 2005-01-13 | Wako Pure Chemical Industries, Ltd. | 分光測定による特定成分の測定方法 |
| US7427508B2 (en) | 2003-10-09 | 2008-09-23 | Organotek Defense System Corporation | Method for assaying multi-component mixtures |
| WO2005069737A2 (en) * | 2004-01-27 | 2005-08-04 | Ramot At Tel Aviv University Ltd. | Method and system for detecting analytes |
| EP1751523B1 (en) | 2004-05-13 | 2017-10-04 | NarTest AS | A portable device and method for on-site detection and quantification of drugs |
| US7966051B2 (en) * | 2005-01-11 | 2011-06-21 | Olympus Corporation | Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method |
| DE102005020384A1 (de) * | 2005-05-02 | 2006-11-09 | Therainvention Gmbh | Spektroskopisches Verfahren zum Nachweis von Analyten |
| WO2009071102A1 (en) | 2007-12-04 | 2009-06-11 | Tallinn University Of Technology | Optical method and device for measuring concentrations of substances in biological fluids |
-
2011
- 2011-06-28 CA CA2837488A patent/CA2837488C/en active Active
- 2011-06-28 AU AU2011274009A patent/AU2011274009B2/en active Active
- 2011-06-28 JP JP2013517023A patent/JP5957450B2/ja active Active
- 2011-06-28 KR KR1020137002066A patent/KR101848527B1/ko active Active
- 2011-06-28 US US13/807,688 patent/US9103789B2/en active Active
- 2011-06-28 CN CN2011800323962A patent/CN102985822A/zh active Pending
- 2011-06-28 WO PCT/EE2011/000008 patent/WO2012000521A1/en not_active Ceased
- 2011-06-28 BR BR112012033625A patent/BR112012033625A2/pt not_active Application Discontinuation
- 2011-06-28 NZ NZ60568511A patent/NZ605685A/en unknown
- 2011-06-28 EP EP11740556.3A patent/EP2585830B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011274009A1 (en) | 2013-01-31 |
| JP2013534630A (ja) | 2013-09-05 |
| JP5957450B2 (ja) | 2016-07-27 |
| NZ605685A (en) | 2014-10-31 |
| CA2837488A1 (en) | 2012-01-05 |
| EP2585830B1 (en) | 2018-04-25 |
| AU2011274009B2 (en) | 2016-06-23 |
| KR101848527B1 (ko) | 2018-04-12 |
| CN102985822A (zh) | 2013-03-20 |
| CA2837488C (en) | 2021-10-26 |
| WO2012000521A1 (en) | 2012-01-05 |
| KR20130038347A (ko) | 2013-04-17 |
| EP2585830A1 (en) | 2013-05-01 |
| US20130193347A1 (en) | 2013-08-01 |
| US9103789B2 (en) | 2015-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012033625A2 (pt) | método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico | |
| TR201820019T4 (tr) | Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit. | |
| BRPI0715718A2 (pt) | Anticorpo, métodos de triar para um anticorpo para o domínio extracelular de uma proteína prlr, de alterar sistematicamente anticorpos e triar para um anticorpo para o domínio extracelular de uma proteína prlr, de tratar um indivíduo que sofre de câncer, de alvejar uma célula tumoral que expressa prlr, de usar uma célula hospedeira, de identificar um indivíduo com necessidade de tratamento com um anticorpo anti-prlr, e de monitorar terapia de câncer em um indivíduo, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, composição farmacêutica, e, kit | |
| AR090884A1 (es) | Moleculas de anticuerpo anti-gcc y uso de las mismas para probar la susceptibilidad a la terapia dirigida a gcc | |
| UA111175C2 (uk) | ЗАСТОСУВАННЯ КОМПОЗИЦІЇ, ЯКА МІСТИТЬ БІСПЕЦИФІЧНЕ АНТИТІЛО CD19xCD3, ДЛЯ ЛІКУВАННЯ ДИФУЗНОЇ B-КРУПНОКЛІТИННОЇ ЛІМФОМИ | |
| MX2012000388A (es) | Prueba de equilibrio peritoneal simplificada para dialisis peritoneal. | |
| BR112013003122A2 (pt) | aparelho para tratamento extracorpóreo de sangue | |
| NZ608208A (en) | Breast cancer diagnostics | |
| DK2114990T3 (da) | Fremgangsmåde til forudsigelse af NSCLC-patienters respons på behandling med en EGFR-TK-inhibitor | |
| BR112012026361A2 (pt) | previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar | |
| BR112014010067A8 (pt) | método e sistema para usar disparos de rastreador para estimar volumes de influxo de fluidos a partir de diferentes zonas de influxo para um fluxo de produção em um poço | |
| BR112014003877A2 (pt) | biomarcadores de micro-rna e métodos de uso dos mesmos | |
| BR112013007046A2 (pt) | método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo | |
| ATE525657T1 (de) | Analytisches einweg-mikroprozessorgerät | |
| WO2022208445A3 (en) | Multiparametric optical method and device for determining uremic solutes, including uremix toxins, in biological fluids | |
| WO2008074029A3 (en) | Protein profile for osteoarthritis | |
| EA201171178A1 (ru) | Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов | |
| RU2013138721A (ru) | Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови | |
| BR112014031958A2 (pt) | bag3 como marcador de tecido e soro bioquímico | |
| BRPI0812348B8 (pt) | método para regulação descedente ou de redução da função biológica de uma proteína,molécula quimérica,vetor recombinate e método para isolar uma proteína de uma amostra | |
| GB2522131A (en) | Isotopic labelling of proteins | |
| RU2015108014A (ru) | Системы и способы минимально инвазивного измерения газов в артериальной крови | |
| EA201200991A1 (ru) | Способ экспресс-определения атерогенности крови | |
| BR112013020241A2 (pt) | métodos de análise de placa | |
| EP2505667A3 (en) | Device and method for analysis of kidney failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: OUE OPTOFLUID TECHNOLOGIES (EE) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |